1. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Issue 4 (10th October 2019) Authors: Torres, Fernando; Farber, Harrison; Ristic, Arsen; McLaughlin, Vallerie; Adams, John; Zhang, Jinkun; Klassen, Preston; Shanahan, William; Grundy, John; Hoffmann, Ines; Cabell, Christopher; Escribano Subías, Pilar; Sood, Namita; Keogh, Anne; D'Souza, Gwyn; Rubin, Lewis Journal: European respiratory journal Issue: Volume 54:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Future perspectives in pulmonary arterial hypertension. (December 2016) Authors: Simonneau, Gérald; Hoeper, Marius M.; McLaughlin, Vallerie; Rubin, Lewis; Galiè, Nazzareno Journal: European respiratory review Issue: Volume 25:Number 142(2016) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis. Issue 2 (22nd August 2019) Authors: Jaafar, Sara; Visovatti, Scott; Young, Amber; Huang, Suiyuan; Cronin, Paul; Vummidi, Dharshan; McLaughlin, Vallerie; Khanna, Dinesh Journal: European respiratory journal Issue: Volume 54:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long‐Term Outcomes in Patients With Connective Tissue Disease–Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta‐Analyses of Randomized, Controlled Trials and Observational Registries. Issue 5 (29th March 2021) Authors: Khanna, Dinesh; Zhao, Carol; Saggar, Rajan; Mathai, Stephen C.; Chung, Lorinda; Coghlan, J. Gerry; Shah, Mehul; Hartney, John; McLaughlin, Vallerie Journal: Arthritis & rheumatology Issue: Volume 73:Issue 5(2021) Page Start: 837 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort. Issue 9 (27th July 2021) Authors: Young, Amber; Moles, Victor M.; Jaafar, Sara; Visovatti, Scott; Huang, Suiyuan; Vummidi, Dharshan; Nagaraja, Vivek; McLaughlin, Vallerie; Khanna, Dinesh Journal: Arthritis & rheumatology Issue: Volume 73:Issue 9(2021) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Issue 8 (18th June 2019) Authors: Young, Amber; Vummidi, Dharshan; Visovatti, Scott; Homer, Kate; Wilhalme, Holly; White, Eric S.; Flaherty, Kevin; McLaughlin, Vallerie; Khanna, Dinesh Journal: Arthritis & rheumatology Issue: Volume 71:Issue 8(2019) Page Start: 1339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pulmonary arterial hypertension: tailoring treatment to risk in the current era. (20th December 2017) Authors: Gaine, Sean; McLaughlin, Vallerie Journal: European respiratory review Issue: Volume 26:Number 146(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Issue 2 (17th August 2017) Authors: Gaine, Sean; Chin, Kelly; Coghlan, Gerry; Channick, Richard; Di Scala, Lilla; Galiè, Nazzareno; Ghofrani, Hossein-Ardeschir; Lang, Irene M.; McLaughlin, Vallerie; Preiss, Ralph; Rubin, Lewis J.; Simonneau, Gérald; Sitbon, Olivier; Tapson, Victor F.; Hoeper, Marius M. Journal: European respiratory journal Issue: Volume 50:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension. Issue 1 (5th January 2023) Authors: Humbert, Marc; McLaughlin, Vallerie; Gibbs, J. Simon R.; Gomberg-Maitland, Mardi; Hoeper, Marius M.; Preston, Ioana R.; Souza, Rogerio; Waxman, Aaron B.; Ghofrani, Hossein-Ardeschir; Escribano Subias, Pilar; Feldman, Jeremy; Meyer, Gisela; Montani, David; Olsson, Karen M.; Manimaran, Solaiappan; ... Journal: European respiratory journal Issue: Volume 61:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The evolving landscape of pulmonary arterial hypertension clinical trials. Issue 10366 (26th November 2022) Authors: Weatherald, Jason; Boucly, Athénaïs; Peters, Anthony; Montani, David; Prasad, Krishna; Psotka, Mitchell A; Zannad, Faiez; Gomberg-Maitland, Mardi; McLaughlin, Vallerie; Simonneau, Gérald; Humbert, Marc Journal: Lancet Issue: Volume 400:Issue 10366(2022) Page Start: 1884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗